Adverse eventsPercentage of participants with any adverse event · patients undergoing knee arthroscopy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Analgesia durationTime duration from the end of surgery to the time of first analgesic consumption. Scale from: 0 to 100. · patients undergoing knee arthroscopy
1 finding from 1 review
Adverse eventsPercentage of participants with any adverse event · patients undergoing knee arthroscopy
Morphine showed no clear difference in adverse eventsPercentage of participants with any adverse event compared with placebo (low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · patients undergoing knee arthroscopy
3 findings from 1 review
no estimate extracted
5 studies · 248 participants
Low
no estimate extracted
6 studies · 330 participants
Low
no estimate extracted
5 studies · 270 participants
Low
Analgesia durationTime duration from the end of surgery to the time of first analgesic consumption. Scale from: 0 to 100. · patients undergoing knee arthroscopy
1 finding from 1 review
Post‐dural puncture headache participant's report · participants undergoing lumbar puncture
Bed rest probably leads to higher post‐dural puncture headacheReported by participant compared with ambulation (moderate certainty).
1 finding from 1 review
Severe post‐dural puncture headache participant's report · participants undergoing lumbar puncture
Bed rest showed no clear difference in severe post‐dural puncture headacheReported by participant compared with ambulation (low certainty).
1 finding from 1 review
Any headacheReported by participant · participants undergoing lumbar puncture
Bed rest probably leads to higher any headacheReported by participant compared with ambulation (moderate certainty).
1 finding from 1 review
Quadriceps muscle strength Handheld or fixed dynamometry · adults with advanced disease for muscle weakness
1 finding from 1 review
Safety Any serious adverse event · adults with advanced disease for muscle weakness
1 finding from 1 review
Safety Adverse events: Muscle discomfort · adults with advanced disease for muscle weakness
1 finding from 1 review
Muscle mass Anthropometry, DEXA, ultrasound, computed tomography · adults with advanced disease for muscle weakness
1 finding from 1 review
Exercise performance ‐ walking distance 6MWT, ISWT, ESWT · adults with advanced disease for muscle weakness
1 finding from 1 review
Change in peak oxygen uptake Cardiopulmonary exercise test · adults with advanced disease for muscle weakness
1 finding from 1 review
Pain (PPI‐VAS) · cancer patients
1 finding from 1 review
Anxiety (state) · cancer patients
1 finding from 1 review
Anxiety · cancer patients
2 findings from 1 review
Symptoms relating to the breast (EORTC QLQ‐BR23): long‐term (≥ 8 weeks) · cancer patients
1 finding from 1 review
Quality of life (change from baseline) in the medium term · cancer patients
1 finding from 1 review
Anxiety · cancer patients
4 findings from 1 review
no estimate extracted
3 studies · 98 participants
Very low
no estimate extracted
1 study · 30 participants
Very low
no estimate extracted
2 studies · 68 participants
Very low
Show 1 more finding